Thank you for your interest, we’ll get in touch with you shortly!
Letterlife is a data-driven precision health tool for girls and women with ADHD. It visualizes the interplay of hormones, symptoms, and lifestyle throughout the female lifespan. By tracking hormonal fluctuations, treatment effects, and real-life outcomes, Letterlife enables tailored, evidence-based pharmacological treatment and self-care. It aims to reduce time to diagnosis, ensure access to healthcare interventions, empower self-efficacy, and promote self-care for girls and women with ADHD.
Building the Next Generations Premenstrual Syndrome (PMS) Care. Femai prioritizes harmonizing female physiology, focusing on PMS. We empower with personalized, compassionate care for PMS management. Our goal: PMS as a stepping stone to strength, allowing each woman to take charge of her unique journey to a more healthy and thriving life.
Acute Doctor is a revolutionary global digital medical platform that addresses the worldwide shortage of doctors. It offers a robust platform for medical providers and Med-Tech companies to effortlessly connect with billions of patients through telehealth and an array of innovative digital features.
We at Pharmista Technologies are on a mission to disrupt the pregnancy testing market which has not been reinvented in over 30 years. To achieve this, we are developing a reusable pregnancy test that is based on a patented platform technology, enabling repeated detection of the target analyte. With 90% of women being interested in replacing todays solutions with our innovation, we are dedicated towards realising this product in the best possible way!
Lillemini empowers parents to cope with sleep related issues during the first 12 months of their children´s lives. Our unique IP is our inhouse platform, content and knowledge based tools related to sleep and how to better understand your baby’s needs and body language based on health research. Started in 2017, profitable in 2019, and reinvesting profits since. Bootstrapped. Monthly membership business model.
PeckiiLess is a Sweden-based company that has created a nano-sensor that can detect blood glucose levels through human exhalation to an extremely accurate level. Hundreds of millions of people, most diabetics, around the world rely on accurate glucose monitoring to lead a healthy life. Current methods are invasive can be painful, are expensive, wasteful and not universally available. PeckiiLess can improve the lives of these people.
Ovulai is a personalized fertility guide that helps women with irregular menstrual cycles to finally understand their overall hormonal health and wellbeing in hopes to improve on their chances of becoming pregnant by interpreting and combining the body naturOvulai AB is the first femtech company to develop a digital care program for chronic menstrual disorders such as PCOS. Our app is based on the latest evidence-based research about lifestyle treatment and offers personalized management programs with curated knowledge combining dietary, exercise and cognitive behavioral intervention in a digital form. We aim to make care programs for chronic menstrual disorders easily accessible and actionable so our users can achieve an improved quality of life.